Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Below are recent peer-reviewed publications from Boston University’s Department of Health Law, Policy and Management. You can find all posts in this series here. After an
My coauthors (Matt Brault and Ben Sommers) and I published a piece in JAMA Health Forum yesterday laying out the challenges inherent to evaluating how
Cecille Joan Avila is a Policy Analyst at Boston University School of Public Health. She tweets at @cecilleavila. Lately, the relationship between unmet social need
The president recently signed an executive order on a handful of health care issues. Among other things, it points to protections for those with preexisting
Paul Shafer is an assistant professor of health law, policy, and management at the Boston University School of Public Health, follow him on Twitter @shaferpr.
The federal response to the Covid-19 pandemic has been criticized as somewhat…disorganized. Joe Biden and Kamala Harris have outlined a plan for how their administration
Last Monday, I spent the day in a hospital — specifically, an Emergency Department (ED) — dealing with an episode of atrial fibrillation. I’ll explain
Decriminalization involves trade-offs, but treating addiction as a disease yields a clear gain, research suggests.
I spent yesterday in the emergency department of the Ottawa hospital. I was being treated for atrial fibrillation — the uncontrolled, rapid beating of my
Across party lines, Americans generally agree that prescription drug prices in the US are unreasonable. But those high domestic drug prices are part of an incentive structure that drives global pharmaceutical innovation. So how can lawmakers balance the priorities of lowering drug prices and maximizing innovation? This post reviews how France and England factor these concerns into their unique approaches to prescription drug pricing.
Paul Ingraham publishes PainScience.com, an evidence-based site about the surprisingly weird science of aches, pains, and injuries. (Full disclosure, some of it is behind a
Dr. Aaron Carroll talks with Dr. Sharon Moe and Dr. Sarah Wiehe, the new co-directors of the Indiana Clinical and Translational Sciences Institute (CTSI). The